Prosecution Insights
Last updated: November 04, 2026

Candesant Biomedical Inc.

Technology area: Medical Devices & Mechanical Engineering

1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready

Analysis

Candesant Biomedical Inc. is currently prosecuting a patent portfolio within the Medical Devices & Mechanical Engineering technology area. The company has 1 pending office action, which is being reviewed by 1 distinct examiner. This focus suggests a highly specific or early-stage prosecution phase for the current filings. The concentration of effort within a technical domain allows for a focused legal strategy but limits the breadth of examiner feedback at this time.

The activity is concentrated within a distinct art unit, aligning with the pending action and examiner. The busiest examiner, DEMIE, TIGIST S, is handling the pending office action. Because this examiner is responsible for the only pending action in the portfolio, the company's immediate strategy must be tailored to the specific requirements of this examiner. The lack of multiple art units or examiners indicates that the current pending workload does not yet span a broad technical or administrative range within the patent office. Consequently, the company's prosecution success is currently tied to the individual review process of the examiner within the Medical Devices & Mechanical Engineering sector.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

1
Total Pending OAs
1
Non-Final OAs
0
Final Rejections
0
Advisory / Quayle

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
1
Medium (100%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
Double-patenting + other1 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

0
Life Sciences
0% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
1
Mechanical / Eng
100% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

10 h
Manual time on pending OAs
2 h
Time saved (low, 20%)
4 h
Time saved (mid, 35%)
0.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
DEMIE, TIGIST S 1 75.2% +20.3%

Interview Candidates (1)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18786421 MEDICAL DEVICES FOR GENERATING HEAT AND METHODS OF TREATMENT USING THE SAME DEMIE, TIGIST S —

Top Art Units

Art UnitApps
3794 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18786421 MEDICAL DEVICES FOR GENERATING HEAT AND METHODS OF TREATMENT USING THE SAME DEMIE, TIGIST S 3794 §103§112DP Non-Final OA — Pending Jul 26, 2024

Managing Candesant Biomedical Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does Candesant Biomedical Inc. have?

Candesant Biomedical Inc. has 1 pending office actions as of November 2026, spread across 1 art units and 1 examiners.

Which USPTO examiner handles the most Candesant Biomedical Inc. applications?

Tigist S Demie has the most, with 1 of Candesant Biomedical Inc.'s pending office actions.

What technology area are Candesant Biomedical Inc.'s patent applications in?

Mostly Medical Devices & Mechanical Engineering (USPTO Tech Center 3700), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month